Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Cannabics Pharmaceuticals Inc (CNBX)

Cannabics Pharmaceuticals Inc (CNBX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 6.37
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2004 +4.29%
on 09/30/19
0.2600 -19.62%
on 09/24/19
-0.0010 (-0.48%)
since 09/18/19
3-Month
0.2004 +4.29%
on 09/30/19
0.3350 -37.61%
on 07/23/19
-0.1010 (-32.58%)
since 07/18/19
52-Week
0.2004 +4.29%
on 09/30/19
0.6650 -68.57%
on 10/22/18
-0.4610 (-68.81%)
since 10/18/18

Most Recent Stories

More News
Cannabics Pharmaceuticals Announces Publication of Clinical Data From Its Sponsored Pilot Study on Controlled Release Capsules, on the Journal of Integrative Cancer Therapies

TEL AVIV, Israel and BETHESDA, Maryland , Oct. 16, 2019 /PRNewswire/ --   Cannabics Pharmaceuticals Inc.  (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer...

CNBX : 0.2090 (-5.00%)
Cannabics Pharmaceuticals Announces Publication of Clinical Data From Its Sponsored Pilot Study on Controlled Release Capsules, on the Journal of Integrative Cancer Therapies

Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that the final results of its pilot study to test the...

CNBX : 0.2090 (-5.00%)
Cannabics Pharmaceuticals Appoints Company's Founder to Its Board of Directors

TEL AVIV, Israel and BETHESDA, Maryland , Oct. 7, 2019 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid based cancer medicine, today announced...

CNBX : 0.2090 (-5.00%)
Cannabics Pharmaceuticals Appoints Company's Founder to Its Board of Directors

Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid based cancer medicine, today announced that it has appointed the Company's Founder as a new Director and Member of its...

CNBX : 0.2090 (-5.00%)
Cannabics Pharmaceuticals to Present Research Data at the 2nd International Cannabinoid Derived Pharmaceuticals Summit in Boston, MA

TEL AVIV , Israel and BETHESDA, Maryland , Sept. 12, 2019 /PRNewswire/ --  Cannabics Pharmaceuticals Inc.  (OTC-QB: CNBX), a leader in personalized cannabis based cancer medicine, today...

CNBX : 0.2090 (-5.00%)
Cannabics Pharmaceuticals to Present Research Data at the 2nd International Cannabinoid Derived Pharmaceuticals Summit in Boston, MA

Cannabics Pharmaceuticals Inc. (OTC-QB: CNBX), a leader in personalized cannabis based cancer medicine, today announced that its Scientific Director, Dr. Ilan Hochman, is scheduled to present research...

CNBX : 0.2090 (-5.00%)
Wize Pharma Completes Milestone for Joint Venture With Cannabics Pharmaceuticals; Companies to Develop Cannabinoid Ophthalmic Treatments

Wize Pharma, Inc. (OTCQB: WIZP) a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, announced today that the Company and Cannabics Pharmaceuticals (OTCQB: CNBX)...

WIZP : 0.2400 (+10.09%)
CNBX : 0.2090 (-5.00%)
Wize Pharma Completes Milestone for Joint Venture With Cannabics Pharmaceuticals; Companies to Develop Cannabinoid Ophthalmic Treatments

HOD HASHARON, Israel , June 28, 2019 /PRNewswire/ -- Wize Pharma , Inc. (OTCQB: WIZP) a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, announced...

CNBX : 0.2090 (-5.00%)
WIZP : 0.2400 (+10.09%)
/C O R R E C T I O N -- Cannabics Pharmaceuticals Inc./

In the news release, Cannabics Pharmaceuticals Appoints Two Independent Directors, issued June 25, 2019 by Cannabics Pharmaceuticals Inc. over PR Newswire, we are advised by the company that the 5th paragraph,...

CNBX : 0.2090 (-5.00%)
Cannabics Pharmaceuticals Appoints Two Independent Directors

TEL AVIV , Israel and BETHESDA, Maryland, June 25, 2019 /PRNewswire/ -- Cannabics Pharmaceuticals Inc.   (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused...

CNBX : 0.2090 (-5.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade CNBX with:

Key Turning Points

2nd Resistance Point 0.2362
1st Resistance Point 0.2226
Last Price 0.2090
1st Support Level 0.2022
2nd Support Level 0.1954

See More

52-Week High 0.6650
Fibonacci 61.8% 0.4875
Fibonacci 50% 0.4327
Fibonacci 38.2% 0.3779
Last Price 0.2090
52-Week Low 0.2004

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar